NON-SMALL CELL LUNG CANCER STAGE IIIA
Clinical trials for NON-SMALL CELL LUNG CANCER STAGE IIIA explained in plain language.
Never miss a new study
Get alerted when new NON-SMALL CELL LUNG CANCER STAGE IIIA trials appear
Sign up with your email to follow new studies for NON-SMALL CELL LUNG CANCER STAGE IIIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New keytruda copycat tested in lung cancer patients
Disease control OngoingThis study compares a new drug, SB27, to the approved cancer medicine Keytruda in people with early-stage non-small cell lung cancer who have already had surgery and chemotherapy. The main goal is to see if SB27 stays in the body the same way as Keytruda. About 163 adults will re…
Matched conditions: NON-SMALL CELL LUNG CANCER STAGE IIIA
Phase: PHASE1 • Sponsor: Samsung Bioepis Co., Ltd. • Aim: Disease control
Last updated May 08, 2026 12:01 UTC
-
New combo therapy aims to keep early lung cancer from coming back
Disease control OngoingThis study tests whether adding the drug durvalumab to targeted radiation (SBRT) helps keep early-stage non-small cell lung cancer from returning. It includes 13 people with stage I to IIIA disease. The main goal is to see if the combination improves how long people live without …
Matched conditions: NON-SMALL CELL LUNG CANCER STAGE IIIA
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated May 06, 2026 16:14 UTC